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In human somatic tissues between 70 and 80% of all cytosine
bases in the sequence CpG are modified in a tissue-specific pattern
by addition of a methyl group at the 5¢ position of the pyrimidine
base. Two kinds of alterations in DNA methylation patterns,
hypermethylation and hypomethylation, respectively, have been
observed in human tumours (Laird et al, 1996; Baylin et al, 1998;
Schulz, 1998). Hypermethylation denotes the increased methyla-
tion of CpG-rich gene promoter sequences restricted to specific
genes or genomic regions. Hypermethylation inactivates, for
instance, the VHL tumour suppresser gene in some renal cell
carcinomas (Herman et al, 1994; Clifford et al, 1998) and the
MTS1/p16INK4 tumour suppresser gene in some urothelial,
prostate and other carcinomas (Gonzalez-Zulueta et al, 1995;
Herman et al, 1995; Merlo et al, 1995; Jarrard et al, 1997). In
contrast, hypomethylation appears to affect the genome at large
and often results in a decreased overall content of methylcytosine.
However, it is not clear which sequences exactly are subject to
hypomethylation. DNA hypomethylation occurs as an early
change in some kinds of carcinomas, but is associated with
progression in others, such as prostate carcinoma (Bedford et al,
1987; Santourlidis et al, 1998). A study of 13 bladder cancers
showed a high prevalence of DNA hypomethylation, but due to the
low number of samples the relationship towards tumour stage and
grade could not be elucidated (Jürgens et al, 1996). A systematic
study in renal cell carcinoma has not been reported.
Genome-wide changes in DNA methylation may, in particular,
affect those repetitive DNA sequences that are comparatively rich in
CpG dinucleotides such as Alu, other SINE, L1 LINE (LINE-1) and
certain satellite sequences that between them contain a considerable
fraction of total methylcytosine in the human genome (Miller et al,
1974). Since DNA methylation also limits the ability of retro-
elements to be activated and transcribed and to participate in recom-
bination, methylation of retrotransposons and proviruses probably
also counteracts their tendency to endanger the stability of the
genome by amplification and recombination (Yoder et al, 1997).
Two very distantly related repetitive retroelements were investi-
gated in this study. LINE-1 retrotransposons constitute up to 15%
of the human genome (Kazazian and Moran, 1998). Complete
elements are 6-kb long containing a CpG-rich internal promoter
located at their 5¢-ends and two open reading frames that encode
an RNA-binding protein and an endonuclease/reverse transcriptase
(Feng et al, 1996). Most LINE-1 elements are defective due
to truncations at their 5¢-end or internal mutations. Their total
number exceeds 105, among which approximately 100 have
remained transposition-competent (Moran et al, 1996). Disruption
of genes by insertion of LINE-1 elements has been found in
human cancer and genetic disease (Morse et al, 1988; Miki et al,
1992; Dombroski et al, 1993; Holmes et al, 1994). In addition,
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Summary Since DNA methylation is considered an important mechanism for silencing of retroelements in the mammalian genome,
hypomethylation in human tumours may lead to their reactivation. The methylation status of LINE-1 retroposons was determined in 73
samples of urinary bladder cancers, 34 specimens of renal cell carcinoma and in the corresponding normal tissues by Southern blot analysis.
LINE-1 sequences were strongly methylated in normal tissues and were significantly hypomethylated in 69 (95%) urothelial carcinomas, but
in none of the renal carcinomas. Hypomethylation in bladder cancers was independent of stage and tended to increase with grade. The
methylation status of HERV-K proviral DNA in normal and transformed urothelial cells paralleled that of LINE-1 sequences (r 2 = 0.87). It was
shown by ligation-mediated polymerase chain reaction that hypomethylation also extended to the LINE-1 promoter sequence located at the
5¢-ends of full-length elements which is repressed by methylation in somatic tissues. Accordingly, full-length LINE-1 transcripts were detected
by Northern blot analysis in two urothelial carcinoma cell lines. In contrast, transcripts from HERV-K proviruses were restricted to
teratocarcinoma cell lines. Our data indicate that genome-wide DNA hypomethylation is an early change in urothelial carcinoma, but is absent
from renal cell carcinoma. The coordinate changes of LINE-1 and HERV-K DNA methylation suggest that hypomethylation in urothelial cancer
affects a variety of different retroelements to similar extents. We speculate that decreased methylation of LINE-1 retroelements, in particular,
may contribute to genomic instability in specific human tumours such as urothelial carcinoma by rendering these normally repressed
sequences competent for transcription and recombination.
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LINE-1 sequences have been identified at or near chromosomal
translocation sites (Nagarajan et al, 1990; Pomykala et al, 1994;
Liu et al, 1997). Presumably to prevent such accidents, most
elements are highly methylated in normal adult tissues (Alves et
al, 1996; Jürgens et al, 1996; Woodcock et al, 1997). Methylation
of the LINE-1 promoter sequence has been shown to repress its
activity (Hata et al, 1996).
The human endogenous retrovirus type K (HERV-K) family
comprises 30–50 full-length members per haploid genome, among
which several contain intact open reading frames (reviewed in
Löwer et al, 1996; Tönjes et al, 1996). Intact elements are flanked
by two long terminal repeats each approximately 1-kb in length
providing the promoter and poly-adenylation signals respectively.
HERV-K are the most intact among human endogenous retroviruses
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Figure 1 Southern blot analysis of LINE-1 methylation in urothelial cancer. (A) Restriction map of LINE-1 elements. Top: restriction map of the cloned element
L1.2B with positions of the MspI/HpaII sites. The location of the PstI fragment used as a probe is indicated. Below: the two groups of double-headed arrows
denote the series of bands resulting from successive mutation or methylation of sites M4 to M1 with or without mutation or methylation of sites M5 and M6 (top
vs bottom). (B) LINE-1 methylation in urothelial carcinoma. Analysis of LINE-1 methylation in six samples of urothelial carcinomas (nos 1, 5, 10, 11, 4, 8). BN:
normal bladder. The sizes of the observed bands are indicated on the right. H: HpaII digestion; M: MspI digestion. Samples 1, 5 and 10 show moderate
hypomethylation, sample 4 weak hypomethylation, and samples 8 and 11 no hypomethylation1314 AR Florl et al
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and make up 1–2% of the human genome. HERV-K sequences are
relatively poor in CpG dinucleotides, for instance there are fewer
than 20 in their long terminal repeats. Nevertheless, methylation of
these sequences like that of LINE-1 sequences may be important in
controlling their ability to be transcribed, to retrotranspose and to
participate in recombination. For instance, LINE-1 (Bratthauer and
Fanning, 1992) and HERV-K (Löwer et al, 1995; Gotzinger et al,
1996) sequences have been shown to be hypomethylated and tran-
scribed in human teratocarcinoma cells.
In the present study, methylation of LINE-1 elements was inves-
tigated in a large number of urothelial carcinoma and renal cell
carcinoma specimens to determine the relationship of hypo-
methylation to tumour stage and tumour grade. To determine its
specificity, hypomethylation of HERV-K sequences was also
investigated. To elucidate whether hypomethylated retroelements
might become reactivated in tumour cells, methylation of the
LINE-1 promoter at their 5¢-end was investigated by a newly
adapted ligation-mediated (LM-) polymerase chain reaction (PCR)
method and the expression of LINE-1 and HERV-K sequences was
compared in bladder carcinoma and teratocarcinoma cell lines.
MATERIALS AND METHODS
Cell lines
Human bladder carcinoma cell lines (Grimm et al, 1995), male
teratocarcinoma Tera-1, NCCIT, and GH, female teratocarcinoma
Pa 1, amnion AV3, choriocarcinoma JAR, Molt 4 T-cell lymphoma
and rhabdomyosarcoma A204 cell lines were cultured as described
(Löwer et al, 1993).
Table 1 LINE-1 hypomethylation and tumour grade and stage in urothelial carcinoma
Hypomethylation
(no. of cases)
Tumour grade None 2–10% 11–20% 20–30% > 30% Total
G1 0 1 0 0 0 1
G2 2 9 5 5 3 24
G3 2 19 8 7 7 43
G4 0 0 3 0 2a 5
Total 4 29 16 12 12 73b
Tumour stage None 2–10% 11–20% 20–30% > 30% Total
pTa 1 2 1 2 2 8
pT1 0 4 2 1 3 10
pT2 2 6 1 2 1 12
pT3 1 12 8 6 4 31
pT4 0 5 4 1 1 11
pTis 0 0 0 0 1 1
Total 4 29 16 12 12 73b
aIncluding one large area carcinoma in situ. bIncluding the 13 tumour samples published in Jürgens et al, 1996.
35 17 22 25 13 15 BN
HM HM HM HM HM HM HM kb
3.4
3.2
3.1
3.0
2.9
1.8
1.6
1.4
1.1
1.0
Renal cell carcinoma
Figure 2 Southern blot analysis of LINE-1 methylation in renal carcinoma. Analysis of LINE-1 methylation in six samples of renal cell carcinoma (nos 35, 17,
22, 25, 13, 15). BN: normal bladder. KN: normal kidney. The sizes of the observed bands are indicated on the right (cf. Figure 1A). H: HpaII digestion; M: MspI
digestionRetroelement methylation in urological tumours 1315
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Patients and tissue samples
Bladder and renal tissue samples were obtained by cystectomy or
nephroureterectomy. Tumours and corresponding normal tissues
were dissected immediately after surgery, 0.1–0.5 g blocks were
frozen in liquid nitrogen and stored at –80°C. In the present study,
60 samples of urothelial carcinoma were investigated in addition
to the 13 samples investigated previously (Jürgens et al, 1996).
Among the 73 patients, 53 were male and 20 were female. Their
mean age was 67 years with a range from 41 to 85 years. In all,
eight tumours were staged as pTa, ten carcinomas as pT1 and 12 as
pT2, 31 as pT3 and 11 as pT4. One tumour was graded as G1, 24
tumours were graded as G2, 43 as G3 and four as G4. One patient
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Figure 3 Southern blot analysis of HERV-K methylation in bladder
carcinoma cell lines. (A) Restriction map of HERV-K proviruses. MspI partial
restriction maps of a cloned provirus are aligned with gene maps of HERV-K
proviruses. Type I and II proviruses are distinguished essentially by the
indicated 292-bp deletion (light grey boxes). Dark boxes below the restriction
map labelled I–IV indicate the locations of the hybridization probes used and
the groups of double-headed arrows labelled in the same fashion at the
bottom of the drawing show the main bands expected upon Southern
analysis. (B) Southern blot analysis. DNA from normal bladder (BN) or from
the indicated bladder carcinoma cell lines was digested with HpaII (H) or
MspI (M), separated, blotted and hybridized with probe II. DNA marker sizes
are indicated on the left side and some of the identified bands (cf. panel A)
on the right side of the blot
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had a large carcinoma in situ. Among the 34 patients with renal
cell carcinoma, 22 were male and 12 were female. Their mean age
was 63 years with a range from 42 to 81 years. One renal carci-
noma was staged as pT1, 23 as pT2, nine as pT3 and one as pT4.
One sample was graded G1 and eight G3, all others were classified
as G2. Six renal carcinomas showed chromophilic histology, the
remainder were clear cell carcinoma. Grading and staging were
performed according to the 1992 UICC classification for bladder
carcinoma and according to the Thoenen classification for renal
cell carcinoma. This study was approved by the Ethics Committee
of the Heinrich-Heine-University.
DNA extraction and Southern blot analysis
DNA extraction was performed as described (Jürgens et al, 1996).
Southern blot analysis was performed using a 0.6-kb PstI fragment
from the cloned (Dombroski et al, 1993) LINE element pL1.2 B
(kindly provided by Dr Kazazian, Baltimore, MD, USA) or frag-
ments from cloned HERV-K proviruses (Löwer et al, 1995) as
detailed in Figures 1A and 3A. The extent of hypomethylation was
quantified by video densitometry as follows. Defined bands in the
1.0–4.0 kb range in the case of LINE-1 elements and the 2.5–
3.1 kb bands resulting from hybridization of HER V-K proviruses
with probe II, were quantified by Gaussian approximation and the
sum of the band intensities in the HpaII lane was divided by the
sum of the band intensities in the MspI lane from the same sample.
This value was corrected for unequal loading of the two lanes
which yielded a factor of less than 1.5 in all cases and the
hypomethylation background of normal bladder or kidney.
LM-PCR
The method was modified from (Steigerwald et al, 1990). Usually
1 mg of DNA was digested with 10 U HpaII or MspI for 4 h. The
linker primer (5¢-GCGGTGACCCGGGAGATCTGAATTC-3¢)
and linker 2 (5¢-CGGAATTCAGATC-3¢) were annealed, and
15 pmole of the product were ligated to 1 mg of digested DNA.
Following removal of the ligase, 300 ng of DNA were amplified
using 12 pmol each of linker primer and either primer F2 (5¢-
TTTTGTTTGTCTGTGCCCTGCCCCC-3¢) or primer F3 (5¢-
ACCTAAGCAAGCCTGGGCAATG-3¢), 0.25 mmol l–1 of each
deoxynucleotide triphosphate, 1.3 U Taq polymerase, 1.5 mmol l–1
magnesium chloride, 50 mmol l–1 potassium chloride, 100 mmol
l–1 Tris, pH 8.3, in a total volume of 50 ml for 13 cycles. The
annealing temperature was 67°C and the extension temperature
73°C. Ten microlitres from each reaction were loaded onto a 2.5%
agarose gel, electrophoresed and blotted to a nylon membrane. The
membrane was probed with linker primer tailed with digoxi-
genin–ddUTP using a 3¢-tailing kit (Boehringer Mannheim,
Germany) at 65°C in 5 ´ standard saline citrate (SSC), 0.1%
lauroyl sarcosine, 0.02% sodium dodecyl sulphate (SDS) and 1%
blocking reagent and washed with 2 ´ SSC, 0.1% SDS and 0.1 ´
SSC, 0.1% SDS twice each for 5 min at 65°C. The labelled probe
was detected by luminescence as described by the supplier
(Boehringer Mannheim, Germany). In vitro methylation of DNA
with  HpaII methylase (New England Biolabs, Bad Homburg,
Germany) was performed as suggested by the supplier.
RNA extraction and Northern blot analysis
Preparation of polyA-selected mRNA and Northern analysis were
performed as described (Löwer et al, 1995). Probes used for
hybridization comprised a 3.4 EcoRI fragment representing the 5¢-
part of the LINE-1 cDNA clone cD11 A (Skowronski et al, 1988)
which was a kind gift of Dr M Singer (Baltimore), a 165 bp
BamHI/EcoRI fragment from the R/U5 region of a HTDV/HERV-
K provirus, and a 1.8 kb PstI fragment from chicken b-actin
(Löwer et al, 1995).
RESULTS
LINE-1 methylation in urothelial tumours
Figure 1 shows the results of a typical Southern blot analysis of
LINE-1 methylation using a 0.6-kb PstI fragment from the cloned
element L1.2B (Dombroski et al, 1993) as a probe. L1.2B contains
eight sites for the restriction enzymes MspI and HpaII numbered
M1–M8 (Figure 1A). Both enzymes recognize the sequence CCGG,
but HpaII is inhibited by methylation of either internal cytosine,
whereas MspI is only inhibited by methylation of an outer cytosine,
which is uncommon in mammalian cells. L1.2B is expected to yield
upon Southern hybridization a 1.4-kb band following restriction with
MspI. Due to the polymorphy of LINE-1 elements, several bands are
observed (Figure 1). Successive loss of the restriction sites M4–M2
yields bands of 1.6 kb, 1.8 kb and 1.9 kb respectively. About half of
all LINE-1 elements hybridizing to the probe lack sites M5 and M6
producing a further series of bands from 3.1 to 3.5 kb. Some of these
bands could theoretically result from elements lacking site M5 only
(cf. Figure 1A). However, since cloned sequences usually lack both
sites, we presume that most bands stem from such elements. Further
recognition sites for the enzyme pair present in individual elements
result in additional bands, most conspicuously at 1.1 and 1.2 kb.
As expected, LINE-1 DNA sequences were strongly methylated
in normal bladder. This is illustrated by the almost complete lack
of specific bands in the smaller than 5 kb range upon HpaII diges-
tion of DNA isolated from normal tissue (Figure 1B). In contrast,
almost all samples of urothelial carcinoma displayed specific
hybridization signals in this size range indicating hypomethylation
of LINE-1 elements compared to normal tissue (Figure 1B). Some
samples showed methylation of LINE-1 elements slightly dimin-
ished compared to normal bladder tissue (specimen no. 8 and no.
11 in Figure 1B), whereas others showed extensive hypomethyla-
tion (specimen no. 1 and no. 5 in Figure 1B). However, some
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Figure 4 Hypomethylation of LINE-1 and HERV-K sequences in urothelial
carcinoma. Hypomethylation of LINE-1 and HERV-K sequences as quantified
by video densitometry of Southern blots using the PstI probe and probe II,
respectively (cf. Figure 1A and 3A), are plotted against each other for 13
urothelial carcinoma samples (open circles) and four cell lines (filled circles)Retroelement methylation in urological tumours 1317
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Figure 5 Ligation-mediated PCR analysis of LINE-1 promoter methylation. (A) LM-PCR products expected from hypomethylated LINE-1 sequences. The two
panels show the series of products expected after ligation-mediated PCR using primers F2 (upper panel) or F3 (lower panel). The positions of the MspI/HpaII
sites (M1–M8) are indicated. The additional MspI site discovered during this study is indicated by an italicized M. Note that all products contain the linker primer.
(B, C) LINE-1 hypomethylation in bladder tissue and urothelial carcinoma cell lines. Results of LM-PCR reaction using primers F2 (B) and F3 (C) respectively.
The four DNA samples investigated were from normal bladder (BN) or the bladder carcinoma cell lines 5637 and HT1376. The BN DNA on the left (labelled
‘methyl’) was methylated with HpaII methylase prior to treatment with restriction enzymes. The sizes of the DNA marker used are indicated on the left and the
probable sizes of the products on the right. H: HpaII digestion; M: MspI digestion
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degree of hypomethylation was found in almost all (69/73 = 95%)
urothelial carcinomas. Hypomethylation was not related to tumour
stage (Table 1). For instance, the extent of hypomethylation ranged
from 0 to 60% in papillary tumours (pTa) and from 5 to 37% in
carcinomas invading neighbouring tissues (pT4). The extent of
hypomethylation tended to increase with tumour grade (Table 1),
but this relationship was not significant (Mantel–Haenszel c2 exact
test: P = 0.127; asymptotic Fisher’s test: P = 0.070).
Methylation of LINE-1 sequences in renal cell
carcinoma
In contrast to urothelial carcinomas, hypomethylation of LINE-1
sequences was not observed in any of 34 renal cell carcinoma
specimens from various stages and grades. A typical Southern blot
analysis is shown in Figure 2.
HERV-K methylation in urothelial carcinoma
Figure 3A displays the structure (top), restriction maps (centre) of
prototypic type I and type II HERV-K along with the location of
the probes I–IV used for Southern hybridization and major frag-
ments expected and found. Type I and II HERV-K proviruses differ
essentially by a 292-bp deletion at the amino-terminus of the env
gene also removing the coding region of the c-orf gene. The recog-
nition sites of MspI and HpaII are labelled M1–M7 according to
their location in the cloned type I proviruses HERV-K10. Note that
site M3 occurs only in this particular provirus.
Methylation of the HERV-K provirus DNA sequences was first
compared in urothelial carcinoma cell lines with different degrees
of LINE-1 hypomethylation (Figure 3B). Following digestion with
MspI, probe II located within the gag region between sites M2 and
M3 yielded mainly two bands of approximately 2.5 kb and 2.7 kb.
The 1.0 kb band resulting from HERV-K10 was also observed in
normal bladder and in two cell lines, but was absent from
VMCub1 and weaker than expected in T24, suggesting loss of this
particular provirus in these cell lines (Figure 3A). The double band
at 2.5 kb and 2.7 kb suggests that approximately half of the HERV-
K proviruses lack site M4. Since cloned type I proviruses, but not
type II proviruses, contain this site (unpublished observations) the
double band reflects essentially the two classes of proviruses (cf.
Figure 3A). In addition to the major bands, a few weaker addi-
tional bands were observed in the MspI digest that may be derived
from truncated or internally deleted elements. Very little signal
was detected in the lower molecular weight range in the HpaII lane
from normal bladder indicating methylation of probably both sites
flanking the probe. Methylation was significantly diminished in all
bladder carcinoma cells with HT1376 DNA almost devoid of
methylation. In the other cell lines a 3.1 kb band was prominent in
the  HpaII lanes that may correspond to the M1–M4 fragment
resulting from selective methylation of site M2. The methylation
pattern in cell line 5637 most closely resembled that in normal
mucosa, whereas the other two cell lines showed intermediate
levels of methylation. This order of degree of methylation was also
seen with the other HERV-K probes indicated in Figure 3A (data
not shown).
HERV-K methylation paralleled LINE-1 methylation in the cell
lines as well as in 13 primary tumours representing various degrees
of LINE-1 hypomethylation (Figure 4, r2 = 0.87). The main differ-
ence was that a low level of LINE-1 hypomethylation was
measured in some tumours without detectable HERV-K
hypomethylation.
LM-PCR analysis of LINE-1 methylation
To analyse the methylation status of the LINE-1 promoter region,
an LM-PCR method was used. A staggered linker was ligated to
the CG overhang resulting from DNA restriction by either HpaII
or MspI, and the ligation products were amplified by PCR using a
linker-primer (LP) and an LINE-1-specific primer. The reaction
products were separated on an agarose gel, blotted and visualized
by hybridization with digoxigenin–ddU-tailed linker primer. Since
specific bands are only produced if a restriction enzyme has cut,
this method yields a positive display of hypomethylated sites in the
HpaII lane. The target-specific primers F2 and F3 (Figure 5A)
were chosen from the sequence of the active element L.1.2B which
upstream of the primers contains four (F2) or three (F3) recogni-
tion sites, respectively, for the restriction enzymes (Figure 5A),
corresponding to sites M1–M4 in Figure 1A. Since LINE-1
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Figure 6 Northern blot analysis of LINE-1 and HERV-K expression in
bladder carcinoma cell lines. Two micrograms mRNA from the cell lines Tera
1 (lane 1), Molt 4 (lane 2), AV3 (lane 3), JAR (lane 4), A 204 (lane 5), Pa 1
(lane 6), 5637 (lane 7) NCCIT (lane 8), HT1376 (lane 9) and GH (lane 10)
were separated on a denaturing agarose gel, blotted and hybridized with
probes against HERV-K (top) or LINE-1 and b-actin (bottom). A slightly
longer exposure of the LINE signal is shown in the centre. The sizes of the
HERV-K mRNAs are indicated on the left in kb and the locations of the
transcripts for LINE-1 and actin are marked on the rightRetroelement methylation in urological tumours 1319
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elements are polymorphic, several PCR products are expected
following  MspI digestion (Figure 5A). All predicted products were
observed in the MspI lane (Figure 5B). An additional band around
400 bp is probably accounted for by LINE-1 elements, e.g. in
the human b-globin locus (EMBL accession number X03145),
containing an additional MspI site at bp 405 while lacking sites
M3 and M4.
A comparison of LINE-1 5¢-end methylation in normal bladder
and the cell lines 5637 and HT1376 revealed that their difference
in overall LINE-1 methylation shown previously (Jürgens et al,
1996) by Southern analysis also extended to the 5¢-ends (Figure 5
B, C). Whereas the bands in the HpaII lanes from normal bladder
and from the cell line 5637 differed in intensity from those in the
MspI lanes, almost identical patterns were observed with HT1376
DNA. However, residual bands were seen in DNA from normal
bladder in the HpaII lane. The F2 primer yielded predominantly
the 121-bp and with lower intensity the 501-bp band (Figure 5B).
The same pattern of bands was also observed in five additional
DNA samples from normal bladder, in normal prostate and in
normal kidney DNA (data not shown). The similar intensity of the
121-bp band in the HpaII and MspI lanes indicates that site M4 is
rarely methylated in those LINE-1 elements annealing with primer
F2. Since no increased intensity was seen in any of the bands orig-
inating from sites M1–M3 with the upstream F3 primer (Figure
5C), these sites are probably methylated in most of these elements
in normal tissue. With primer F3, the 297-bp band corresponding
to the 405-bp band upon use of primer F2 did not appear. Indeed,
the LINE-1 elements from the b-globin locus contain several base
changes in the region corresponding to primer F3 compared to
LINE-1.2B. Methylation of DNA from normal bladder with HpaII
methylase in vitro prior to enzyme digestion and LM-PCR did not
alter the band pattern in the MspI lanes, but caused a complete
disappearance of the bands in the HpaII lanes (Figure 5 B, C)
confirming their origin from unmethylated sites.
In contrast to the 121-bp band, the intensities of all other bands
increased in the HpaII lanes from most bladder carcinoma cell
lines and primary tumour samples compared to normal bladder
(Figure 5 B, C). For instance, the 501-bp band whose presence
indicates hypomethylation of site M2 in some LINE-1 elements
was much weaker in the HpaII lane from normal bladder than in
HT1376 DNA, and its intensity increased in many tumour
samples. Eight tumour samples investigated by both Southern blot
analysis and by LM-PCR gave concordant results with both
methods (data not shown) indicating that hypomethylation of
LINE-1 sequences in urothelial carcinoma also extends to their 5¢-
ends containing the promoter sequence.
Expression of retroelements in carcinoma cell lines
To investigate the expression of LINE-1 and HERV-K mRNAs, a
Northern blot containing polyA-selected RNA from the bladder
carcinoma cell lines 5637 and HT1376, several teratocarcinoma
cell lines and others from different tissue origin was successively
hybridized with probes for HERV-K, LINE-1 and b-actin (Figure
6). The HERV-K probe detected transcripts exclusively in the three
male teratocarcinoma cell lines Tera 1, NCCIT and GH (lanes 1, 8
and 10 in Figure 6). The 1.5-kb mRNA with unknown coding
function and the 1.8-kb c-orf mRNA were very strongly expressed
in all three cell lines, whereas the 3.5-kb env mRNA and the 8.8-
kb genomic RNA were present at much lower levels. None of the
other cells showed a comparable level of transcription. Expression
of 6-kb LINE-1 transcripts was also most prominent in
the teratocarcinoma cell lines, but these transcripts were also
observed (in decreasing order of expression levels) in the female
teratocarcinoma, in the bladder carcinoma cell lines HT1376 and
5637, and in the T-lymphoma cell line Molt 4.
DISCUSSION
The present study reveals substantial differences in DNA methyla-
tion between urothelial and renal cell carcinoma. In urothelial
carcinoma, in accord with our initial report (Jürgens et al, 1996)
hypomethylation of LINE-1 sequences was highly prevalent. The
substantial number of tumour specimens investigated in the two
studies allows the conclusion that hypomethylation is not related
to tumour stage but that higher grade tumours tend to more
pronounced hypomethylation. High prevalence throughout all
tumour stages and grades is the hallmark of an early change.
Therefore these data suggest that hypomethylation of LINE-1
sequences is an early event during the development of urothelial
cancer. Since the number of low-grade and low-stage tumours in
our study was small, a more extensive study of early stage urothe-
lial tumours and their precursors is needed to definitely answer this
issue. Urothelial carcinoma in this respect may resemble colon
cancer (Goelz et al, 1985; Feinberg et al, 1988), but obviously
differs from prostate carcinoma where hypomethylation seems
to be associated with tumour progression (Bedford et al, 1987;
Santourlidis et al, 1999). Renal cell carcinoma obviously belongs
to a distinct class of tumours which lack DNA hypomethylation
altogether. Interestingly, hypermethylation of CpG-islands in the
promoter regions of tumour suppressor genes has been described
in renal cell carcinoma as well (Makos et al, 1993; Herman et al,
1995; Clifford et al, 1998). Thus, hypermethylation appears to
occur in renal cell carcinoma independently from hypomethylation
suggesting that these alterations in DNA methylation are not
necessarily linked to each other. Since hypermethylation of a
crucial tumour suppresser gene will provide a selective advantage
for the affected tumour cell, it is conceivable that incidental alter-
ations of DNA methylation in crucial genes such as the von-
Hippel–Lindau gene are selected for in renal cell carcinoma,
whereas the multiple alterations of DNA methylation patterns in
urothelial carcinoma may be due to overall deregulation of DNA
methylation.
The relative methylation of LINE-1 retrotransposons and of
HERV-K proviruses were highly significantly correlated in urothe-
lial carcinoma cell lines as well as in primary tumours (Figure 4).
Although both classes of sequences belong to the general category
of retroelements, they are very distantly related and differ strongly
in their overall content and distribution of methylation target
sites. Therefore, DNA hypomethylation in urothelial carcinoma
involves quite different sequences to a similar extent and can truly
be designated ‘genome-wide’. Conversely, this finding confirms
that methylation of LINE-1 sequences can serve as a good marker
of changes in overall DNA methylation in human tumours.
Deregulation of DNA methylation is thought to contribute to
genomic instability in human tumours, although the mechanisms
involved are not understood. Reactivation of retroelements
might represent a particularly important consequence of DNA
hypomethylation, since their containment is a key function of
DNA methylation in mammalian genomes (Yoder et al, 1997).
Retrotransposition of LINE-1 sequences results in a highly
unstable branched DNA structure prone to undergoing recombina-tion with accessible elements located nearby or even elsewhere in
the genome (Feng et al, 1996). Chromosome deletions and translo-
cations probably caused by retrotransposition events have indeed
been observed in several human cancers (Morse et al, 1988;
Nagarajan et al, 1990; Miki et al, 1992; Pomykala et al, 1994; Liu
et al, 1997). The decrease in promoter methylation in urothelial
tumour cells and the occurrence of full-length LINE-1 transcripts
in two bladder carcinoma cell lines with hypomethylated DNA
(Figure 6) raises the possibility of retrotransposition occurring in
urothelial carcinoma. The frequency of retrotransposition events
has been found to be very high in a transfection system using
retroposition-competent tagged LINE-1 elements (Moran et al,
1996) but a quantitative estimate of the frequency of retroposition
events in tumour cells is not yet available. A second consequence
of DNA hypomethylation of repetitive sequences could be
increased mitotic recombination (Chen et al, 1998) which requires
the open chromatin structure usually associated with hypomethyl-
ated DNA. In this regard, the limited number of bands seen upon
hybridization of Southern blots with LINE-1 probes (cf. Figure 1)
suggests a remarkable degree of sequence conservation among
these elements which may facilitate homologous recombination.
In contrast to LINE-1 transcripts, HERV-K transcripts could not
be detected in bladder carcinoma cell lines, but rather were
restricted to male teratocarcinoma cell lines. Assuming that
hypomethylation of these sequences is related to their expression,
there are two potential explanations for this finding. For one, the
crucial sites in the HERV-K LTR may not have become demethyl-
ated, since the most proximal site investigated (M1, located
approximately 300-bp downstream from the start of transcription)
was only demethylated in the cell line HT1376, but not in 5637. It
remains possible therefore that demethylation of one or several of
the approximately 12 CpG sites upstream of M1 is crucial for tran-
scription of HERV-K proviruses. The situation is different with the
LINE-1 promoter which comprises the CpG rich 5¢-end of the
elements. The first 200 bp act as the actual promoter whose func-
tion is supported by the adjacent downstream 500 bp (Swergold,
1990). The results of Southern analysis and LM-PCR indicate that
sites M1–M3 located within the basal promoter and site M4
located in the supporting region are demethylated in carcinomas
with DNA hypomethylation in many LINE-1 elements allowing
transcription. Alternately, the LINE-1 promoter contains mainly
binding sites for ubiquitous transcription factors, whereas the
HERV-K LTR may be activated by cell type-specific proteins
restricted to developing germ cells. Therefore, diminished methyl-
ation of these promoters may lead to activation of both kinds of
promoters in teratocarcinoma cells, but of only LINE-1 promoters
in somatic cells.
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